Autolus Therapeutics PLC (AUTL)
4.08
-0.13
(-3.09%)
USD |
NASDAQ |
Apr 25, 11:27
Autolus Therapeutics Market Cap: 1.085B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.120B |
| April 23, 2024 | 1.191B |
| April 22, 2024 | 1.213B |
| April 19, 2024 | 1.202B |
| April 18, 2024 | 1.276B |
| April 17, 2024 | 1.287B |
| April 16, 2024 | 1.292B |
| April 15, 2024 | 1.303B |
| April 12, 2024 | 1.335B |
| April 11, 2024 | 1.417B |
| April 10, 2024 | 1.370B |
| April 09, 2024 | 1.444B |
| April 08, 2024 | 1.444B |
| April 05, 2024 | 1.489B |
| April 04, 2024 | 1.465B |
| April 03, 2024 | 1.460B |
| April 02, 2024 | 1.465B |
| April 01, 2024 | 1.510B |
| March 28, 2024 | 1.697B |
| March 27, 2024 | 1.659B |
| March 26, 2024 | 1.641B |
| March 25, 2024 | 1.683B |
| March 22, 2024 | 1.681B |
| March 21, 2024 | 1.662B |
| March 20, 2024 | 1.742B |
| Date | Value |
|---|---|
| March 19, 2024 | 1.441B |
| March 18, 2024 | 1.442B |
| March 15, 2024 | 1.353B |
| March 14, 2024 | 1.325B |
| March 13, 2024 | 1.274B |
| March 12, 2024 | 1.253B |
| March 11, 2024 | 1.257B |
| March 08, 2024 | 1.327B |
| March 07, 2024 | 1.253B |
| March 06, 2024 | 1.316B |
| March 05, 2024 | 1.325B |
| March 04, 2024 | 1.346B |
| March 01, 2024 | 1.448B |
| February 29, 2024 | 1.395B |
| February 28, 2024 | 1.378B |
| February 27, 2024 | 1.427B |
| February 26, 2024 | 1.471B |
| February 23, 2024 | 1.420B |
| February 22, 2024 | 1.411B |
| February 21, 2024 | 1.441B |
| February 20, 2024 | 1.548B |
| February 16, 2024 | 1.588B |
| February 15, 2024 | 1.646B |
| February 14, 2024 | 1.685B |
| February 13, 2024 | 1.592B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
161.30M
Minimum
Dec 12 2022
1.742B
Maximum
Mar 20 2024
538.64M
Average
474.59M
Median
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 267.81M |
| Biodexa Pharmaceuticals Plc | 3.026M |
| NuCana PLC | 7.908M |
| TC BioPharm (Holdings) PLC | 5.112M |
| Mereo BioPharma Group PLC | 387.11M |
Market Cap Related Metrics
| Price to Book Value | 9.733 |
| Price | 4.08 |
| Earnings Yield | -29.41% |